• Working Hours - Mon - Thu: 8:00 - 17:00; Fri: 8:00 - 14:00
What are you looking for?

Blog

IHVN Participates at the 2025 Union World Conference in Copenhagen

The Institute of Human Virology Nigeria (IHVN) has participated in the World’s Largest Lung Health Conference, the 2025 Union World Conference on Lung Health, in Copenhagen, Denmark from November 18th to 21st.

The conference brings together government and non-government agencies, charities, donors and funders, professional groups, patient groups, civil society organisations, clinicians, managers, policy makers, front-line workers and implementers, scientists, patients and survivors, advocates and the civil society to address tuberculosis and lung diseases.

At the conference, IHVN presented 19 e-posters and 12 oral abstracts at the event highlighting research findings in areas such as community approaches for tuberculosis prevention and screening, private sector involvement in tuberculosis case finding and use of digital technologies.

IHVN also collaborated with Red AID Nigeria, Association of Reproductive and Family Health (ARFH), Caritas Nigeria, KNCV Nigeria and Damien Foundation to present 12 e-posters and ten oral presentations at the event

IHVN Director of Special Projects, Dr Aderonke Agbaje said the conference has been engaging with significant insights gained in tuberculosis science and implementation.

“It has provided a rich environment for IHVN to share experiences with experts on implementation and research efforts, while networking with experts, researchers and product developers. This experience has reinvigorated the team to do more in addressing inequities in TB response,” she said.

By participating both in number and depth of research, IHVN continues to collaborate in shaping global conversations around TB and HIV, even as it applies these insights within the country.

Click Link to view Abstract Presentation details.

IHVN Celebrates October Employees of the Month

In fostering an excellent work culture and staff performance, the Executive Management of the Institute of Human Virology Nigeria (IHVN) has initiated the “Employee Recognition Awards” to recognize “Employees of the Month” and “Employee of the Year.”

According to the IHVN Director of Finance and Administration, Mr. Olu Alabi, this recognition covers overall employee performance in dressing, innovation, teamwork, productivity, efficiency, leadership and interpersonal skills, punctuality, and adherence to company values and principles, amongst other things.

For October 2025, IHVN celebrates Kevin Chikodili Ugwuanyi, Temitope Olukomogbon, Shumtywal Peace Danjuma, Daharatu Yahaya, Tolulope Olufemi, Ayomide Olumefun, Fausat Alaya-Bashir, Uchechukwu Akubelem, Safia Sani, Isaac Bajeh, Frederick Saiki, Tuamsen Shindes and Umar Aliyu, whose performance stood out in their teams.

Hearty cheers to our October star performers!

NORA 2025 Summer School Focuses on Strengthening Capacity for Cancer Research and Control

Cancer remains a major public health challenge in Africa, responsible for an estimated 533,000 deaths annually, with breast and cervical cancers accounting for the majority of cases among women.

To reduce cancer mortality through improved prevention, diagnosis, and care across Sub-Saharan Africa, the Network for Oncology Research in Sub-Saharan Africa (NORA) Consortium has hosted a five-day summer school in Abuja.

The event was hosted by the International Research Center of Excellence (IRCE) at Institute of Human Virology Nigeria in collaboration with the African Cancer Registry Network (AFCRN) and the National Institute for Cancer Research and Treatment (NICRAT). It attracted participants from NORA partner institutions in Ethiopia, Tanzania, Nigeria, and South Africa.

IRCE, which is one of the NORA partner institutions, welcomed researchers, clinicians and policy makers to the event, themed “Building Capacity for Cancer Research and Control in Africa,”

Through plenary sessions, workshops, and hands-on training, participants explored innovative solutions to the challenges of early detection, limited treatment access, and inadequate data for cancer control in low-resource settings.

Speaking at the Summer School’s Opening Session, NORA Nigeria Principal Investigator, Dr. Elima Jedy-Agba explained that the program comprises five African countries working collaboratively to reduce cancer morbidity and mortality through research and innovation.

She noted that the event convened 155 delegates from 25 countries, including experts from Germany, the United Kingdom, Scotland, and the United States.

“Our aim is to produce evidence that shapes public health policy and enhances cancer outcomes for women across Sub-Saharan Africa. Since NORA Consortium began in 2023, it has supported the establishment and strengthening of cancer registries across partner countries, enhancing data quality and comparability. It has also trained over 100 early-career researchers, clinicians, and data officers in cancer epidemiology, implementation science, and data management. NORA continues to generate multi-country data on breast and cervical cancer incidence, stage at diagnosis, and treatment outcomes, informing national policy dialogues,” Dr. Jedy-Agba stated.

IRCE Executive Director, Prof. Alash’le Abimiku said that cancer registries are key in addressing cancer in the country.

“We have done a good job in moving data forward but what we have not done is have quality data across the continent that really shows what the problem is and what our intervention is doing to tackle the problem, now through the cancer registries, we have been able to improve that situation across the country,” Prof. Abimiku said.

Also at the program, the Honorable Minister of State for Health, Dr. Adekunle Salako, said the event demonstrates a collective commitment to strengthening cancer control systems in Nigeria and across Africa.

Dr. Salako was represented by his Special Adviser on Research and Innovation, Dr. Ololade Dosunmu-Adeyemi. He said that through partnerships such as NORA and AFRCRN, Nigeria is moving closer to a future where every citizen, regardless of location or socioeconomic status, can benefit from timely detection, diagnosis, and care informed by real data.